Alzheimer’s Disease/Dementia News

Those with amnestic mild cognitive impairment who used the BrainHQ app for visual speed and attention exercises improved neuropsychological measures of speed, attention, memory and connectivity.

Together Senior Health, a digital therapeutics and cognitive health firm, has announced the launch of its cognitive health platform, which it hopes will reduce the impact of memory loss in those with Alzheimer’s disease and dementia.

Patients with Alzheimer’s disease who are treated with lecanemab have shown the potential to reaccumulate brain amyloid after removal of the drug, a speaker said at the 2022 American Academy of Neurology annual meeting.

The American Psychiatric Association on Wednesday announced the launch of PsychPRO 2.0, a mental health registry that offers psychiatrists enhanced options to engage with patients, track outcomes and streamline data for quality reporting.

CMS announced that Medicare is limiting coverage of the controversial Alzheimer’s disease drug Aduhelm to participants who are enrolled in FDA- or NIH-approved clinical trials.

Cyclica and Arctoris have expanded their partnership to progress drug discovery programs for novel neurodegenerative targets, focusing on Alzheimer’s disease, according to a press release.

Moderate to vigorous physical activity was associated with decreased risk of disabling dementia in men, according to a study published in JAMA Network Open.

Younger or older age at menarche, younger age at first birth, and hysterectomy — all of which affect lifetime exposure to endogenous estrogen — were associated with a higher risk for dementia in women, researchers found.

SEATTLE — Self-administered home use of gamma sensory stimulation reduced brain atrophy safely in people with Alzheimer’s disease, a presenter said at the 2022 American Academy of Neurology annual meeting.

Quanterix Corp. announced it has partnered with the Alzheimer’s Drug Discovery Foundation to accelerate the development of a multi-analyte plasma test for early detection of Alzheimer’s disease.